Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

IMCR US Equity

Immunocore Holdings plcHealth Care · Biological Products, (No Diagnostic Substances) · CIK 1671927 · FY ends Dec 31
$36.86
+0.84 (+2.33%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Vestal Point Capital, LPsec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by WELLINGTON MANAGEMENT GROUP LLPsec.gov ↗
2026-08-0613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-06

Every row is a filed document, checked against its EDGAR index.